Physician profile
Richard Harris Jadick
NPI 1083837975
$47,044.67
in general payments reported to CMS, 2019-2025
37 companies · $2,519 in 2025
The $2,519 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,049 · 2020: $959 · 2021: $24K · 2022: $9,730 · 2023: $4,016 · 2024: $2,564 · 2025: $2,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,919 · Travel and Lodging: $4,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,918.71 |
| Travel and Lodging | $4,180.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $32,710.55 | 2021-2024 | Urolift |
| Coloplast Corp | $3,063.28 | 2020-2025 | Titan, Speedicath, Genesis |
| Axonics, INC. | $2,839.24 | 2020-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $2,044.89 | 2019-2021 | |
| Procept Biorobotics Corporation | $1,933.73 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Neotract INC. | $1,583.66 | 2019-2020 | |
| Boston Scientific Corporation | $1,103.95 | 2019-2025 | Ams 700, Lithoclast, Axonics |
| Sumitomo Pharma America, INC. | $277.15 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $232.86 | 2019-2023 | Myrbetriq |
| Endo Pharmaceuticals INC. | $121.94 | 2019-2022 | |
| Palette Life Sciences, INC. | $97.58 | 2022 | |
| Medtronic, INC. | $88.65 | 2021-2024 | Interstim, Venaseal |
| Urovant Sciences INC | $83.43 | 2022 | |
| Janssen Biotech, INC. | $72.21 | 2025 | Erleada |
| Calyxo, INC. | $59.25 | 2025 | Cvac Aspiration System |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Jadick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.